ArticleGynecologic oncology2017

Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.

Lainie P Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.